Track Paratek Pharmaceuticals's other assets ($0) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2023), PRTK shows a other assets of $0. That compares with $33M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, PRTK's other assets is now $0 (was $33M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Paratek Pharmaceuticals is outperforming or lagging.
Tracking PRTK's other assets over time shows whether Paratek Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $33M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this other assets page, Stockcircle has Paratek Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other assets (currently $0) with ownership activity and broader fundamentals.
Paratek Pharmaceuticals's other assets is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.